# Abbott Ireland Diagnostics Division

- Location (FDA's records): Longford, IE
- FDA decisions: 8 (2021–2023): 8 510(k) clearances
- Product codes: CIG (1), CHH (1), CGX (1), CJE (1), CJW (1), CDQ (1), JFJ (1), CIX (1)
- Predicates its devices cite: 8 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Abbott Laboratories: 8 (https://510kreport.com/company/abbott-laboratories)

## Recent decisions
- K223317: Alkaline Phosphatase2 (Jul 21, 2023)
- K223324: Total Bilirubin2 (Dec 29, 2022)
- K203597: Cholesterol2 (Jun 30, 2022)
- K203771: Urea Nitrogen2 (May 31, 2022)
- K210633: Amylase2 (May 26, 2022)
- K210452: Creatinine2 (Mar 22, 2022)
- K203530: Albumin BCP2 (Mar 18, 2022)
- K203248: Albumin BCG2 (Nov 23, 2021)

Source page: https://510kreport.com/company/abbott-ireland-diagnostics-division